IDEAS home Printed from https://ideas.repec.org/a/gam/jijerp/v20y2023i2p1583-d1036711.html
   My bibliography  Save this article

Impact of COVID-19 in Patients with Lung Cancer: A Descriptive Analysis

Author

Listed:
  • Damian Mojsak

    (2nd Department of Lung Diseases and Tuberculosis, Medical University of Białystok,14 Żurawia Street, 15-540 Bialystok, Poland)

  • Michał Dębczyński

    (2nd Department of Lung Diseases and Tuberculosis, Medical University of Białystok,14 Żurawia Street, 15-540 Bialystok, Poland)

  • Beata Kuklińska

    (2nd Department of Lung Diseases and Tuberculosis, Medical University of Białystok,14 Żurawia Street, 15-540 Bialystok, Poland)

  • Łukasz Minarowski

    (2nd Department of Lung Diseases and Tuberculosis, Medical University of Białystok,14 Żurawia Street, 15-540 Bialystok, Poland)

  • Agnieszka Kasiukiewicz

    (Department of Geriatrics, Medical University of Białystok, 27 Fabryczna Street, 15-471 Bialystok, Poland)

  • Anna Moniuszko-Malinowska

    (Department of Infectious Diseases and Neurology, Medical University of Białystok, 14 Żurawia Street, 15-540 Bialystok, Poland)

  • Piotr Czupryna

    (Department of Infectious Diseases and Neurology, Medical University of Białystok, 14 Żurawia Street, 15-540 Bialystok, Poland)

  • Robert Marek Mróz

    (2nd Department of Lung Diseases and Tuberculosis, Medical University of Białystok,14 Żurawia Street, 15-540 Bialystok, Poland)

Abstract

The COVID-19 pandemic poses a challenge to health systems worldwide. Limiting healthcare availability may delay early diagnosis and worsen the treatment effects of various diseases, including oncological diseases. We analyzed patients presenting to the 2nd Department of Lung Diseases and Tuberculosis in Białystok, Poland, with suspicion of lung cancer 12 months prior to the COVID-19 pandemic (pre-COVID-19) and, similarly, 12 months after the outbreak of the pandemic (mid-COVID). In total, 320 patients were analyzed—132 prior to and 188 after the COVID-19 outbreak. During the COVID-19 period, there was a lower percentage of patients presenting with ECOG performance status 0-1, with a noticeably increased percentage of patients with ECOG PS ≥2. The disease’s clinical stage (CS) was higher on admission during COVID-19. We observed more use of immunotherapy and more deaths before the start of treatment during the COVID-19 period. These results provide insight into the early effects of the COVID-19 pandemic on lung cancer patients and underscore the importance of conducting further studies to assess the long-term effects of the COVID-19 pandemic on this population.

Suggested Citation

  • Damian Mojsak & Michał Dębczyński & Beata Kuklińska & Łukasz Minarowski & Agnieszka Kasiukiewicz & Anna Moniuszko-Malinowska & Piotr Czupryna & Robert Marek Mróz, 2023. "Impact of COVID-19 in Patients with Lung Cancer: A Descriptive Analysis," IJERPH, MDPI, vol. 20(2), pages 1-12, January.
    • Handle: RePEc:gam:jijerp:v:20:y:2023:i:2:p:1583-:d:1036711
    as

    Download full text from publisher

    File URL: https://www.mdpi.com/1660-4601/20/2/1583/pdf
    Download Restriction: no
    File URL: https://www.mdpi.com/1660-4601/20/2/1583/
    Download Restriction: no
    ---><---

    Corrections

    All material on this site has been provided by the respective publishers and authors. You can help correct errors and omissions. When requesting a correction, please mention this item's handle: RePEc:gam:jijerp:v:20:y:2023:i:2:p:1583-:d:1036711. See general information about how to correct material in RePEc.

    If you have authored this item and are not yet registered with RePEc, we encourage you to do it here. This allows to link your profile to this item. It also allows you to accept potential citations to this item that we are uncertain about.

    We have no bibliographic references for this item. You can help adding them by using this form .

    If you know of missing items citing this one, you can help us creating those links by adding the relevant references in the same way as above, for each refering item. If you are a registered author of this item, you may also want to check the "citations" tab in your RePEc Author Service profile, as there may be some citations waiting for confirmation.

    For technical questions regarding this item, or to correct its authors, title, abstract, bibliographic or download information, contact: MDPI Indexing Manager (email available below). General contact details of provider: https://www.mdpi.com .

    Please note that corrections may take a couple of weeks to filter through the various RePEc services.

    IDEAS is a RePEc service. RePEc uses bibliographic data supplied by the respective publishers.